rs28933981

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 3P and 6B. PM1PP3BP4_StrongBP6BS2_Supporting

The ENST00000237014.8(TTR):​c.416C>T​(p.Thr139Met) variant causes a missense change. The variant allele was found at a frequency of 0.0027 in 1,614,166 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T139T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 6 hom. )

Consequence

TTR
ENST00000237014.8 missense

Scores

11
4
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1B:12O:1

Conservation

PhyloP100: 6.09
Variant links:
Genes affected
TTR (HGNC:12405): (transthyretin) This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 6 uncertain in ENST00000237014.8
PP3
Multiple lines of computational evidence support a deleterious effect 8: BayesDel_addAF, BayesDel_noAF, Cadd, Dann, Eigen, M_CAP, MutationAssessor, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster, PrimateAI, PROVEAN was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.04956785).
BP6
Variant 18-31598647-C-T is Benign according to our data. Variant chr18-31598647-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 13434.We mark this variant Likely_benign, oryginal submissions are: {Likely_pathogenic=1, Benign=7, Likely_benign=4}. Variant chr18-31598647-C-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 261 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TTRNM_000371.4 linkuse as main transcriptc.416C>T p.Thr139Met missense_variant 4/4 ENST00000237014.8 NP_000362.1
LOC124904277XR_007066326.1 linkuse as main transcriptn.129-2952G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TTRENST00000237014.8 linkuse as main transcriptc.416C>T p.Thr139Met missense_variant 4/41 NM_000371.4 ENSP00000237014 P1
TTRENST00000649620.1 linkuse as main transcriptc.416C>T p.Thr139Met missense_variant 6/6 ENSP00000497927 P1
TTRENST00000610404.5 linkuse as main transcriptc.320C>T p.Thr107Met missense_variant 4/45 ENSP00000477599

Frequencies

GnomAD3 genomes
AF:
0.00172
AC:
261
AN:
152180
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00275
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00151
AC:
379
AN:
251440
Hom.:
0
AF XY:
0.00155
AC XY:
210
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.00107
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.00284
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.00281
AC:
4103
AN:
1461868
Hom.:
6
Cov.:
31
AF XY:
0.00274
AC XY:
1990
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.000448
Gnomad4 AMR exome
AF:
0.00123
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.000412
Gnomad4 NFE exome
AF:
0.00349
Gnomad4 OTH exome
AF:
0.00194
GnomAD4 genome
AF:
0.00171
AC:
261
AN:
152298
Hom.:
0
Cov.:
32
AF XY:
0.00169
AC XY:
126
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.000722
Gnomad4 AMR
AF:
0.00235
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.00275
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00232
Hom.:
3
Bravo
AF:
0.00170
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00279
AC:
24
ExAC
AF:
0.00147
AC:
179
EpiCase
AF:
0.00262
EpiControl
AF:
0.00296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Benign:12Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 22, 2020- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineSep 15, 2021The p.Thr139Met variant in TTR is classified as benign because it has been identified in 0.3% (351/129156) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). Additionally, this variant has been reported in both unaffected individuals as well as in individuals with asymptomatic euthyroid hyperthyroxinemia (Scrimshaw 1992, Alves 1997). Functional and clinical studies indicate that this variant may provide protective benefit against TTR amyloidosis by improving protein stability and reducing the propensity to form amyloidogenic aggregates (Quintas 1997, Almeida 2000, Hammarstrom 2001, Costa 2008, Palhano 2009, Borgault 2011). ACMG/AMP Criteria applied: BA1. -
Benign, criteria provided, single submitterclinical testingGeneDxMay 22, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:3
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2024TTR: BS1 -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 28, 2023- -
Amyloidosis, hereditary systemic 1 Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Hyperthyroxinemia, dystransthyretinemic Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingCambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine ServiceSep 01, 2023PS3,PS4_Moderate,PP4 -
Charcot-Marie-Tooth disease Benign:1
Likely benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioJun 21, 2018- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 08, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
AMYLOIDOSIS, HEREDITARY SYSTEMIC 1, MODIFIER OF Other:1
risk factor, no assertion criteria providedliterature onlyOMIMSep 28, 2001- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.43
BayesDel_addAF
Pathogenic
0.16
D
BayesDel_noAF
Pathogenic
0.46
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.85
D;D;T;.
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.96
.;D;D;D
M_CAP
Pathogenic
0.68
D
MetaRNN
Benign
0.050
T;T;T;T
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Pathogenic
3.3
M;M;.;.
MutationTaster
Benign
1.0
A
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-2.0
.;N;.;.
REVEL
Pathogenic
0.68
Sift
Uncertain
0.0090
.;D;.;.
Sift4G
Uncertain
0.0040
.;D;D;D
Polyphen
1.0
D;D;.;.
Vest4
0.79, 0.86, 0.73
MVP
0.99
MPC
1.4
ClinPred
0.11
T
GERP RS
6.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.42
gMVP
0.87

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28933981; hg19: chr18-29178610; COSMIC: COSV52701482; COSMIC: COSV52701482; API